相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Healthcare and socioeconomic costs of NAFLD: A global framework to navigate the uncertainties
Alina M. Allen et al.
JOURNAL OF HEPATOLOGY (2023)
An improved method for isolation and flow cytometric characterization of intrahepatic leukocytes from fatty and fibrotic liver tissues
Rajani Kandhi et al.
ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY (2023)
An inducible model for genetic manipulation and fate-tracing of PDGFR & beta;-expressing fibrogenic cells in the liver
Florian Hamberger et al.
SCIENTIFIC REPORTS (2023)
Hepatic Stellate Cells: Dictating Outcome in Nonalcoholic Fatty Liver Disease
Leke Wiering et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2023)
Hepatic fibrosis: 2022 Unmet needs and a blueprint for the future
Scott L. Friedman et al.
HEPATOLOGY (2022)
Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis
Aveline Filliol et al.
NATURE (2022)
Hepatic Stellate Cell-Immune Interactions in NASH
James K. Carter et al.
FRONTIERS IN ENDOCRINOLOGY (2022)
Heterogeneity of HSCs in a Mouse Model of NASH
Sara Brin Rosenthal et al.
HEPATOLOGY (2021)
Mechanisms and disease consequences of nonalcoholic fatty liver disease
Rohit Loomba et al.
CELL (2021)
Hepatic Stellate Cell Activation and Inactivation in NASH-Fibrosis-Roles as Putative Treatment Targets?
Alexandra Zisser et al.
BIOMEDICINES (2021)
Identification of Lineage-Specific Transcription Factors That Prevent Activation of Hepatic Stellate Cells and Promote Fibrosis Resolution
Xiao Liu et al.
GASTROENTEROLOGY (2020)
Liver fibrosis is driven by protease-activated receptor-1 expressed by hepatic stellate cells in experimental chronic liver injury
Lauren G. Poole et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2020)
Essential role of suppressor of cytokine signaling 1 (SOCS1) in hepatocytes and macrophages in the regulation of liver fibrosis
Euphrasie Kawila Mafanda et al.
CYTOKINE (2019)
TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis-Updated 2019
Bedair Dewidar et al.
CELLS (2019)
Hepatic stellate cells secrete Ccl5 to induce hepatocyte steatosis
Byeong-Moo Kim et al.
SCIENTIFIC REPORTS (2018)
Transforming Growth Factor-β (TGF-β) Directly Activates the JAK1-STAT3 Axis to Induce Hepatic Fibrosis in Coordination with the SMAD Pathway
Liu-Ya Tang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Targeting hepatic macrophages to treat liver diseases
Frank Tacke
JOURNAL OF HEPATOLOGY (2017)
Mechanisms of hepatic stellate cell activation
Takuma Tsuchida et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Both MAPK and STAT3 signal transduction pathways are necessary for IL-6-dependent hepatic stellate cells activation
Polina Kagan et al.
PLOS ONE (2017)
Hepatic stellate cells as key target in liver fibrosis
Takaaki Higashi et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Liver macrophages in tissue homeostasis and disease
Oliver Krenkel et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Negative regulation of the hepatic fibrogenic response by suppressor of cytokine signaling 1
Rajani Kandhi et al.
CYTOKINE (2016)
Pathogenesis of Nonalcoholic Steatohepatitis
Mariana Verdelho Machado et al.
GASTROENTEROLOGY (2016)
Nonalcoholic Fatty Liver Disease: Fibrosis Portends a Worse Prognosis
Dawn M. Torres et al.
HEPATOLOGY (2015)
Fibrosis Stage Is the Strongest Predictor for Disease-Specific Mortality in NAFLD After Up to 33 Years of Follow-Up
Mattias Ekstedt et al.
HEPATOLOGY (2015)
β-PDGF receptor expressed by hepatic stellate cells regulates fibrosis in murine liver injury, but not carcinogenesis
Peri Kocabayoglu et al.
JOURNAL OF HEPATOLOGY (2015)
NAFLD: A multisystem disease
Christopher D. Byrne et al.
JOURNAL OF HEPATOLOGY (2015)
Hepatic fibrosis: Concept to treatment
Christian Trautwein et al.
JOURNAL OF HEPATOLOGY (2015)
Regulation of MET receptor tyrosine kinase signaling by suppressor of cytokine signaling 1 in hepatocellular carcinoma
Y. Gui et al.
ONCOGENE (2015)
SOCS proteins in regulation of receptor tyrosine kinase signaling
Julhash U. Kazi et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
O147 HEPATIC STELLATE CELLS ARE THE MAJOR SOURCE OF COLLAGEN IN MURINE MODELS OF LIVER FIBROSIS
C.H. Österreicher et al.
JOURNAL OF HEPATOLOGY (2014)
Hepatic Macrophages But Not Dendritic Cells Contribute to Liver Fibrosis by Promoting the Survival of Activated Hepatic Stellate Cells in Mice
Jean-Philippe Pradere et al.
HEPATOLOGY (2013)
An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis
Masahiko Matsumoto et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2013)
NAFLD, NASH and liver cancer
Gregory A. Michelotti et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology
Ingmar Mederacke et al.
NATURE COMMUNICATIONS (2013)
Fibrosis-dependent mechanisms of hepatocarcinogenesis
David Y. Zhang et al.
HEPATOLOGY (2012)
Macrophage Deletion of SOCS1 Increases Sensitivity to LPS and Palmitic Acid and Results in Systemic Inflammation and Hepatic Insulin Resistance
Nirupa Sachithanandan et al.
DIABETES (2011)
Suppressor of cytokine signaling 1 (SOCS1) limits NFκB signaling by decreasing p65 stability within the cell nucleus
Julia Strebovsky et al.
FASEB JOURNAL (2011)
TLR4 enhances TGF-β signaling and hepatic fibrosis
Ekihiro Seki et al.
NATURE MEDICINE (2007)
Liver fibrosis induced by hepatic overexpression of PDGF-B in transgenic mice
Piotr Czochra et al.
JOURNAL OF HEPATOLOGY (2006)
Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation
A Mansell et al.
NATURE IMMUNOLOGY (2006)
Smad2 and smad3 play different roles in rat hepatic stellate cell function and α-smooth muscle actin organization
M Uemura et al.
MOLECULAR BIOLOGY OF THE CELL (2005)
Interleukin-6 protects hepatocytes from CCl4-mediated necrosis and apoptosis in mice by reducing MMP-2 expression
MB Bansal et al.
JOURNAL OF HEPATOLOGY (2005)
Regulation of PDGF and its receptors in fibrotic diseases
JC Bonner
CYTOKINE & GROWTH FACTOR REVIEWS (2004)
SOCS1 is a suppressor of liver fibrosis and hepatitis-induced carcinogenesis
T Yoshida et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
SOCS3 negatively regulates IL-6 signaling in vivo
BA Croker et al.
NATURE IMMUNOLOGY (2003)
SOCS1/JAB is a negative regulator of LPS-induced macrophage activation
I Kinjyo et al.
IMMUNITY (2002)
Suppressors of cytokine signalling (SOCS) in the immune system
WS Alexander
NATURE REVIEWS IMMUNOLOGY (2002)
Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient mice
K Kovalovich et al.
HEPATOLOGY (2000)